Johnson & Johnson (JNJ)

138.42
0.19 0.14
NYSE : Health Technology
Prev Close 138.61
Open 138.61
Day Low/High 137.68 / 138.96
52 Wk Low/High 118.62 / 148.99
Volume 4.49M
Avg Volume 6.20M
Exchange NYSE
Shares Outstanding 2.66B
Market Cap 366.96B
EPS 5.70
P/E Ratio 25.59
Div & Yield 3.80 (2.63%)
Crowning Achievement: Six Dividend Kings With 50+ Years of Rising Dividends

Crowning Achievement: Six Dividend Kings With 50+ Years of Rising Dividends

These 'recession-resistant' names have proven they can thrive in a variety of economic conditions and through changing technologies and sentiments.

The Charts and Indicators on Johnson & Johnson Are Still Mostly Bearish

The Charts and Indicators on Johnson & Johnson Are Still Mostly Bearish

Johnson & Johnson is among the companies that Jim Cramer has put on his new GLOOM index.

Jim Cramer: A GLUM Index For Gloomy Markets

Jim Cramer: A GLUM Index For Gloomy Markets

Taking the measure of what's keeping the markets in the dumps.

Tesla, Boeing and Merck Among Companies Hurt by Latest Tariffs

Tesla, Boeing and Merck Among Companies Hurt by Latest Tariffs

The latest announcement from the U.S. Trade Representative's office is chilling reading for free trade supporters.

Latest Reasons to Avoid Alzheimer's Plays

Latest Reasons to Avoid Alzheimer's Plays

Eli Lilly, AstraZeneca and vTv Therapeutics show why it's best to stay away from biotech's black hole.

Jim Cramer: Tech Can't Do it All Alone

Jim Cramer: Tech Can't Do it All Alone

Tech and retail gains aren't enough to lead markets to new highs.

Intermediate Trade: Johnson & Johnson

Intermediate Trade: Johnson & Johnson

JNJ is one of the best of breed of the pharmaceuticals sector.

Knowledge Is Power in Buy & Sell Decisions

Knowledge Is Power in Buy & Sell Decisions

Johnson & Johnson is a premiere company, but the trick is knowing when to buy it.

How to Play the Long Side of Johnson & Johnson

How to Play the Long Side of Johnson & Johnson

Shares of the healthcare giant pick up a quant rating upgrade as the charts suggest gains ahead.

2 Trading Opportunities in Health Care

2 Trading Opportunities in Health Care

The potential of these setups on the weekly chart is rather good.

Checked the 52-Week Low List Lately? It's a Graveyard of Well-Known Stocks

Checked the 52-Week Low List Lately? It's a Graveyard of Well-Known Stocks

What's really surprising is the emergence of so many household names on the list.

Jim Cramer: Reports of FANG's Death Greatly Exaggerated

Jim Cramer: Reports of FANG's Death Greatly Exaggerated

The big story is about cloud adoption.

Where (and How) to Find 'Dividend Aristocrats'

Where (and How) to Find 'Dividend Aristocrats'

The Nasdaq U.S. Broad Dividend Achievers Index is a good place to start.

Jim Cramer: Markets Seek Domestic Tranquility

Jim Cramer: Markets Seek Domestic Tranquility

Stock markets ran higher as investors turned towards domestic-focused companies.

60 Seconds: Own Dividend Stocks And Get Paid While The Market Tanks (Video)

60 Seconds: Own Dividend Stocks And Get Paid While The Market Tanks (Video)

It's hard to watch the market fall. But knowing you're still getting paid while it happens can make it much more palpable. That's why you need to have some dividend-producing stocks in your portfolio. Watch our video to find out why!

Closing Bell: LIVE MARKETS BLOG

Closing Bell: LIVE MARKETS BLOG

Markets were able to close the day in the green after a volatile day of trading.

Jim Cramer: Will the Techs Be Challenged, Too?

Jim Cramer: Will the Techs Be Challenged, Too?

The theft of intellectual property can be confronted by a Section 301 challenge directly from the trade representative.

An Updated Technical Strategy on Johnson & Johnson

An Updated Technical Strategy on Johnson & Johnson

Let's check and see how things are going.

Cramer: The Right Stocks Rallied Today

Cramer: The Right Stocks Rallied Today

Merger news, healthcare gains, industrials and even airlines joined the party.

Johnson & Johnson Poised to Move Higher, Buy Available Weakness

Johnson & Johnson Poised to Move Higher, Buy Available Weakness

With JNJ now set to close above $134, another look is in order.

Jim Cramer: You Have to Decide If You Want to Profit From This Moment

Jim Cramer: You Have to Decide If You Want to Profit From This Moment

We have a different kind of market where you must know the SYMBOLS and know what the companies do that are the symbols.

Jim Cramer: Drug Stocks on the Move

Jim Cramer: Drug Stocks on the Move

We could be poised for even a further advance PROVIDED that we stay oversold.

The Decline In Johnson & Johnson Could Be Close to Being Over

The Decline In Johnson & Johnson Could Be Close to Being Over

How do the charts look now and is it safe to consider being a buyer again?

Jim Cramer: These 4 Stocks Seem Attractive Right Here

Jim Cramer: These 4 Stocks Seem Attractive Right Here

There is nothing wrong with Intel, Johnson & Johnson, 3M and Apple.

Cramer: This Is a Market Reset

Cramer: This Is a Market Reset

We are in a good-is-now-bad world.

Caution Flag Is Out on Johnson & Johnson's Stock

Caution Flag Is Out on Johnson & Johnson's Stock

With JPMorgan, Berkshire Hathaway and Amazon disrupting the health care space this morning a fresh look at JNJ is in order.

Dollar Decimation Creates Buy Opportunity

Dollar Decimation Creates Buy Opportunity

The time is right to buy this consumer products giant.

Cramer: Time to Throw Out The Old Rules

Cramer: Time to Throw Out The Old Rules

Stocks don't react to bad news the way they used to.

President Trump's Trade War Begins

President Trump's Trade War Begins

It's no secret that President Trump abhors trade deficits.

Jim Cramer: The 3 Best Sectors That Lifted the Stock Market

Jim Cramer: The 3 Best Sectors That Lifted the Stock Market

It's hard to understand the magnitude of the change.